Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions

Publications

Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Interim CEO Appointed to Medicines Australia

The Board of Medicines Australia has appointed Mr Lee Hill to the role of Interim CEO. Mr Hill joins Medicines Australia with over 10 years of experience as a senior business leader, having held CEO and Managing Director roles in a number of leading companies and consultancies across Australia. Mr Wes Cook, Chair of Medicines…

View article· Thursday, 14 January 2016

Medicines Australia CEO

Medicines Australia CEO Tim James today announced his resignation effective January 2016 from the leadership role of the pharmaceutical sector peak body. Medicines Australia Interim Chairman Wes Cook thanked Tim for his strong contribution to the Australian medicines industry during a very difficult period for the sector: “Tim has been a passionate advocate for the…

View article· Saturday, 19 December 2015

Innovation focus will deliver benefits to Australia

Medicines Australia welcomes the Turnbull Government’s National Innovation and Science Agenda and its recognition that innovation is a key to economic growth. The growing policy focus on innovation from all sides of politics is positive news not only for the Australian economy, but ultimately the livelihoods and health of all Australians. Medicines Australia CEO Tim…

View article· Monday, 7 December 2015

PBS medicines save $7 Billion in Hospital Costs

A new report has found that investing in new medicines pays for itself by reducing other public health expenditure. The modelling, published in The impact of pharmaceutical innovation on premature mortality, hospital separations, and cancer survival in Australia, was conducted by American economist Professor Frank Lichtenberg. Medicines Australia CEO Tim James said, “This comprehensive study…

View article· Tuesday, 24 November 2015

Patient Medicine Records Should Be Included In eHealth Data

Medicines Australia has called on the Federal Government to make a patient’s medication records a mandatory inclusion in eHealth profiles to improve the safe use of medicines. The option has been put in a submission to the Senate inquiry into the Government’s eHealth legislation which seeks to make changes to the Personally Controlled Electronic Health…

View article· Thursday, 5 November 2015

Appointment of Medicines Australia Board of Directors and interim-Chairman

Mr Wes Cook, Managing Director of Boehringer Ingelheim Australia, has been selected as the interim-Chairman of Medicines Australia. The appointment was made at the first meeting of the new Board of Directors following the Medicines Australia Annual General Meeting in Sydney today. The decision to appoint a temporary Chairman follows the retirement of Dr Martin…

View article· Tuesday, 20 October 2015

Chairman of Medicines Australia

Medicines Australia today announced that its Chairman, Dr Martin Cross, will retire from the Board upon the conclusion of the current Board term on 20 October 2015. Dr Cross was appointed to the Board of Medicines Australia and made Chairman in 2013 after nearly 30 years in the global pharmaceutical industry. Among the positive progress…

View article· Monday, 12 October 2015

High Court decision could undermine development of innovative medicine

The High Court decision to disallow patenting of isolated genetic materials is of concern to innovative medicines sector. “It is essential that Australia maintains strong and stable intellectual property protection that will support the development of new biological medicines,” said Medicines Australia CEO Tim James. “We will need to consider the implications of this decision…

View article· Wednesday, 7 October 2015

TPP a missed opportunity for the Australian Biopharmaceutical Community

The outcomes of the negotiations for the Trans-Pacific Partnership agreed to in Atlanta overnight are a disappointing outcome and a missed opportunity to stimulate and grow the Australian biopharmaceutical industry. Just last month, the Prime Minister declared that innovation would be at the centre of the Federal Government; the decision not to support greater data…

View article· Tuesday, 6 October 2015

Australian Healthcare Leaders Unite in Support of Transparency

National health professional and consumer organisations have voiced their support for the transparency changes in the new Medicines Australia 18th Code of Conduct, which has come into effect from today. CEO of Medicines Australia, Tim James, said it’s great to see the support of important healthcare leaders including the Pharmacy Guild of Australia, Consumers Health…

View article· Thursday, 1 October 2015

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Social

Congratulations @ScienceChiefAu Prof. Ian Chubb on a wonderful term as Chief Scientist. A tireless advocate for #science R&D.

Interim CEO Appointed to Medicines Australia https://t.co/6I2ZMbSI5B

Congratulations @GSK_AU on their new vaccines facility in Boronia #Melbourne. Fantastic Aussie #innovation at work. https://t.co/3ixA8K2OF9

RT @EthicalStrat: Great to see New @medicinesaus Chair Wes Cook bringing everyone together behind innovation @sussanley @emmamkeogh https:/…

Great talks on Aust #innovation in biopharma for @sussanley. Inc. Vesna Crisp from @AstraZeneca Sydney adv man plant https://t.co/vbUtsY1xTk

Lucky to have Aust Health Min @sussanley open two MA member buildings in a week! @abbvie and @Novartis in Sydney https://t.co/irlMdgmopH

RT @biotech_daily: .@innovationaus National Innovation Science Agenda Comment: - #Biotech_Daily, @Ausbiotech, @MedicinesAus - subscribe…

Great to have Health Minister @sussanley visiting Bennelong today to learn about the great things MA members do. https://t.co/7eWU0iIrA4

Innovation focus will deliver benefits to Australia https://t.co/RXCH077LM5

RT @ThePharmaLetter: Australia cuts down public health bill by investing in new medicines under PBS - Report https://t.co/Ul3oWjsh4v

RT @jcboyce: Great to be sitting with @ShayneNeumannMP and @TeresaGambaroMP at the @PharmGuildAus dinner. A night to talk about a healthy f…

RT @pharmacydaily: #PBS funded innovative medicines have created hospital sector savings of $7b - new report released by @MedicinesAus http…